Healthcare systems play a central role in shaping access to Multiple Sclerosis (MS) care. In this international expert discussion, neurologists explore how national healthcare policies, treatment pathways and multidisciplinary approaches influence clinical practice and patient outcomes.

This Paradigms Foundation webinar brings together international MS experts to discuss how healthcare systems influence the management of Multiple Sclerosis.

Drawing on experiences from Egypt, Denmark, Germany, Greece and Serbia, the panel explores differences in treatment access, healthcare organisation and the implementation of clinical recommendations. The discussion offers perspectives on current challenges and potential improvements in MS care delivery.

Key Insights from the Lecture:

• Navigate differences in treatment access: Explore how national guidelines, reimbursement procedures and healthcare policies influence access to disease-modifying therapies.
• Strengthen multidisciplinary MS care: Understand the importance of coordinated services, including rehabilitation, psychological support and specialist consultations.
• Consider the long-term impact of treatment decisions: Examine how healthcare costs, disability prevention and real-world evidence can inform clinical and policy decisions.
• Support patient-centred care: Discover approaches to shared decision-making, patient-reported outcomes and meaningful patient involvement.
• Learn from international experiences: Identify opportunities for collaboration and knowledge exchange across healthcare systems.

How Healthcare Systems Impact Treatment Choice in Multiple Sclerosis

Please subscribe to watch.

Log-in or subscribe

Summary

Access to comprehensive Multiple Sclerosis (MS) care varies considerably between healthcare systems. Differences in treatment guidelines, reimbursement policies, resource allocation and service organisation can influence therapeutic decisions and continuity of care. In this expert discussion, neurologists from several countries share their experiences of navigating these challenges. The panel examines the role of multidisciplinary MS centres, national registries and real-world evidence in supporting clinical practice and healthcare planning.

The discussion also addresses the importance of long-term health economic perspectives, collaboration between stakeholders and patient involvement in treatment decisions. By comparing different national approaches, the webinar highlights opportunities to strengthen coordinated, evidence-based and patient-centred MS care.

About the Moderator

About the speakers

The discussion features MS specialists from Egypt, Denmark, Germany, Greece and Serbia, including:

Professor of Neurology at the Faculty of Medicine, University of Belgrade

Professor of Neurology at the Aristotle University of Thessaloniki

Director of the Danish Multiple Sclerosis Registry

Head of the Multiple Sclerosis Unit at the Ain Shams Specialized University Hospital

Funding

This webinar was organized with the financial support of Sandoz.

Sandoz has not been involved in the elaboration of the presentations.

We value your opinion.

How likely are you to recommend this material to a friend or colleague?

Selected Value: 1

Give a score from 1 (= not at all likely) to 10 (extremely likely)

Tell us what you think or ask a question to the expert.

Give your opinion on the quality of the material and send us your comments, questions or feedback. Where relevant, we'll liaise with the Expert and get back to you.

Email

If you have submitted a question above, leave your email so we can get back to you.

you Email colleague?

Submit